ANF vs MTH

ANF has a stable Piotroski F-Score of 6/9, indicating moderate financial health, but lacks an Altman Z-Score, limiting definitive conclusions on bankruptcy risk. The stock trades above both the Graham Number ($81.46) and intrinsic value estimate ($71.89), suggesting overvaluation, despite strong profitability metrics like 40.89% ROE and 12.77% ROA. While revenue growth is positive at 6.80%, earnings are contracting YoY (-5.6%) and QoQ (-14.4%), and insider selling signals caution. Analysts recommend a 'buy' with a high target price of $127.56, but recent price performance shows significant short-term weakness (-24% in 1M).

MTH presents a stark contrast between strong defensive valuation and deteriorating operational health. The Piotroski F-Score of 3/9 indicates weak financial health, corroborated by a severe collapse in earnings (-51.50% YoY) and revenue (-17.70% YoY). While the stock trades below book value (P/B 0.88) and below its Graham Number ($96.94), the growth-based intrinsic value of $38.36 suggests the market is pricing in a significant downturn. The combination of bearish insider activity and four consecutive earnings misses offsets the attractive valuation metrics.